Zydus Lifesciences Financials

NSE: ZYDUSLIFE | BSE: 532321

₹1,119.10

up-down-arrow1.30 (0.12%)

As on 11-Sep-2026IST

Market cap

info icon

₹1,11,671 Cr

Revenue (TTM)

info icon

₹28,592 Cr

P/E Ratio

info icon

24.7

P/B Ratio

info icon

4.1

Div. Yield

info icon

0.1 %

Income Statement (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Operating Revenue
28,591.70
27,148.40
23,241.50
19,547.40
17,237.40
15,109.90
Total Income
30,111.40
28,943.00
23,701.10
19,916.80
17,712.00
15,500.60
Total Expenditure
21,334.70
19,958.40
16,348.00
14,248.40
13,665.50
11,935.20
EBITDA
7,257.00
7,190.00
6,893.50
5,299.00
3,571.90
3,174.70
Depreciation
1,724.60
1,408.00
915.80
764.10
722.70
713.00
EBIT
5,532.40
5,782.00
5,977.70
4,534.90
2,849.20
2,461.70
Interest
510.20
438.90
191.00
81.20
129.90
127.00
Other Income
1,519.70
1,794.60
459.60
369.40
474.60
390.70
Exceptional Items
-534.80
-516.60
-219.60
-14.20
-604.20
112.70
Profit before Tax
6,007.10
6,621.10
6,026.70
4,808.90
2,589.70
2,838.10
Provision for Tax
1,514.90
1,594.70
1,411.90
977.50
587.80
511.70
Profit after Tax
4,492.20
5,026.40
4,614.80
3,831.40
2,001.90
2,326.40
Minority Interest
-79.70
-83.50
-147.10
-113.30
-131.60
-131.00
Share of Associate
100.50
97.10
57.80
118.40
94.60
46.20
Consolidated Profit
4,513.00
5,040.00
4,525.50
3,859.50
1,960.30
4,487.30

Liabilities (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Shareholder's Funds
27,111.40
27,111.40
23,953.10
19,829.50
17,515.80
16,999.60
Minority Interest
-79.70
2,470.80
2,405.30
2,272.10
2,172.50
2,054.20
Non-Current Liabilities
7,112.50
5,003.90
-542.10
193.10
-725.00
-193.60
Current Liabilities
15,711.90
15,711.90
9,041.60
5,339.70
5,526.70
7,826.80
Total Liabilities
52,406.60
50,672.60
36,689.10
28,834.30
25,562.00
27,641.60

Assets (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Non-Current Assets
31,677.20
30,391.90
17,811.80
16,135.20
14,477.60
14,438.20
Current Assets
19,906.10
19,906.10
17,046.10
11,419.80
10,008.20
12,095.20
Total Assets
52,406.60
50,672.60
36,689.10
28,834.30
25,562.00
27,641.60
Total Debt*
--
11,769.50
3,169.50
768.60
1,163.20
4,196.00
Net Current Assets
4,194.20
4,194.20
8,004.50
6,080.10
4,481.50
4,268.40
Contingent Liabilities
--
989.90
731.80
753.20
801.10
655.60

Cashflow (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Cash From Operating Activities
--
2,116.60
6,781.10
3,196.30
2,688.80
2,104.50
Cash Flow from Investing Activities
--
-8,296.10
-8,357.80
-1,475.20
1,535.00
-1,000.30
Cash from Financing Activities
--
5,806.90
1,995.30
-1,778.80
-4,400.40
-868.30
Net Cash Inflow / Outflow
--
-372.60
418.60
-57.70
-176.60
235.90

Financials Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Adjusted EPS (₹) info
49.00
50.10
44.99
38.36
19.37
43.82
Cash EPS (₹) info
45.24
63.96
54.98
45.68
26.92
29.68
Adjusted Book Value (₹) info
270.31
269.50
238.10
197.11
173.08
166.01
Dividend per Share (₹) info
0.09
1.00
11.00
3.00
6.00
2.50
Cash Flow per Share (₹) info
--
21.04
67.41
31.77
26.57
20.55
Free Cash Flow per Share (₹) info
--
4.14
53.41
27.70
14.41
14.88

Profitability Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
ROCE (%) info
--
21.39
26.06
24.90
13.64
15.30
ROE (%) info
18.78
19.69
21.08
20.52
11.60
15.51
ROA (%) info
10.03
11.81
14.77
14.70
7.82
9.40
EBIT Margin (%) info
19.35
21.30
25.72
23.20
16.53
16.29
Net Margin (%) info
14.92
17.37
19.47
19.24
11.30
15.01
Cash Profit Margin (%) info
--
12.45
12.11
12.12
8.03
10.28

Growth Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Revenue Growth (%) info
21.11
16.81
18.90
13.40
14.08
4.90
EBIT Growth (%) info
-8.99
-3.27
31.82
59.16
15.74
-9.35
Net Profit Growth (%) info
4.14
8.92
20.45
91.39
-13.95
5.48
EPS Growth (%) info
-1.13
11.37
17.26
98.06
-55.80
110.32
Book Value Growth (%) info
--
13.19
20.80
13.21
3.04
30.84

Valuation Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Price / Earnings info
24.74
17.39
19.69
26.20
25.37
7.96
Price / Book Value info
4.14
3.23
3.72
5.10
2.84
2.10
Dividend Yield (%) info
0.09
0.11
1.24
0.30
1.22
0.72
EV/EBITDA info
13.90
10.91
12.15
17.78
12.44
10.88
Close Price (₹) info
1,112.60
871.20
886.40
1,007.35
491.55
348.50
High Price (₹) info
1,128.50
1,059.05
1,324.30
1,030.15
494.95
673.70
Low Price (₹) info
835.50
795.00
855.10
482.55
319.00
331.00
Market Cap (₹ Cr) info
1,11,670.55
87,643.18
89,100.94
1,01,128.47
49,740.24
35,706.88

Solvency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debt to Equity info
0.12
0.43
0.13
0.04
0.07
0.25
Short term debt to equity ratio info
--
0.16
0.13
0.04
0.06
0.19
Current Ratio info
1.27
1.27
1.89
2.14
1.81
1.55
Quick Ratio info
0.91
0.91
1.45
1.50
1.19
1.07
Interest Coverage info
12.77
16.09
32.55
60.22
20.94
23.35

Operating Efficiency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debtors to sales (%) info
18.94
19.95
17.58
26.71
25.62
22.11
Asset Turnover info
0.64
1.21
1.46
1.46
1.32
1.19
Receivable days info
--
33.55
37.17
46.37
41.75
39.94
Inventory Days info
--
33.80
29.51
32.98
38.39
42.95
Payable days info
--
149.82
150.48
147.51
145.80
166.64
Cash Conversion Cycle info
--
-82.46
-83.79
-68.16
-65.67
-83.76
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...